These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 415815)

  • 1. T-lymphocyte mediated lysis of tumor cells in the presence of alloantiserum.
    Liepins A; Faanes RB; Choi YS; de Harven E
    Cell Immunol; 1978 Mar; 36(2):331-44. PubMed ID: 415815
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of capping H-2 antigens on the susceptibility of target cells to humoral and T cell-mediated lysis.
    Ekidin M; Henney CS
    Nat New Biol; 1973 Nov; 246(150):47-9. PubMed ID: 4202329
    [No Abstract]   [Full Text] [Related]  

  • 3. Lysis of enucleated tumor cells with allogeneic and syngeneic cytotoxic thymus-derived lymphocytes.
    Hale AH; Paulus LK
    Eur J Immunol; 1979 Aug; 9(8):640-6. PubMed ID: 227696
    [No Abstract]   [Full Text] [Related]  

  • 4. Diminished cellular cytotoxicity in mice hyperimmunized prior to skin grafting.
    Sugarbaker PH
    Cell Immunol; 1981 Jan; 57(1):99-113. PubMed ID: 6783318
    [No Abstract]   [Full Text] [Related]  

  • 5. Quantitative approaches to the assessment of cell-mediated immune responses to solid tumor allografts.
    MacDonald HR; Lees RK; Howell RL
    Transplant Proc; 1978 Jun; 10(2):339-42. PubMed ID: 97826
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on the induction and expression of T cell-mediated immunity. XI. Inhibition of the "lethal hit" in T cell-mediated cytotoxicity by heterologous rat antiserum made against alloimmune cytotoxic T lymphocytes.
    Hiserodt JC; Bonavida B
    J Immunol; 1981 Jan; 126(1):256-62. PubMed ID: 6161164
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of cytolysis by thymus-derived lymphocytes. Implications in tumor immunity.
    Henney CS
    Prog Exp Tumor Res; 1974; 19():203-16. PubMed ID: 4373780
    [No Abstract]   [Full Text] [Related]  

  • 8. Modulation of natural cytotoxicity by alloantibodies. I. Alloantisera enhancement of cytotoxicity of mouse spleen cells toward a human myeloid cell line.
    Saxena RK; Adler WH
    J Immunol; 1979 Aug; 123(2):846-51. PubMed ID: 110883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.
    Paciucci PA; Macphail S; Zarling JM; Bach FH
    J Immunol; 1980 Jan; 124(1):370-5. PubMed ID: 6765969
    [No Abstract]   [Full Text] [Related]  

  • 10. Further characterization of thymic suppressor cells and a factor that suppress the generation of cells cytotoxic for a syngeneic tumor in DBA/2 mice.
    Levy JG; Maier T; Kilburn DG
    J Immunol; 1979 Mar; 122(3):766-71. PubMed ID: 109502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immunity to Murine tumor allografts. Increase in the activities of activated thymus-derived cells following in vitro incubation.
    Gorczynski RM; Tigelaar RE
    Cell Immunol; 1975 Jul; 18(1):121-43. PubMed ID: 806353
    [No Abstract]   [Full Text] [Related]  

  • 12. Lymphocyte-mediated cytolysis of allogeneic tumor cells in vitro. I. Search for target antigens in subcellular fractions.
    Todd RF; Stulting RD; Amos DB
    Cell Immunol; 1975 Aug; 18(2):304-23. PubMed ID: 806359
    [No Abstract]   [Full Text] [Related]  

  • 13. Interaction of isoantibody and cytotoxic lymphocytes with allogeneic tumor cells.
    Faanes RB; Choi YS
    J Immunol; 1974 Jul; 113(1):279-88. PubMed ID: 4208919
    [No Abstract]   [Full Text] [Related]  

  • 14. Stimulator T cells: involvement in the induction of cell-mediated cytotoxicity.
    Dennert G
    J Immunol; 1975 May; 114(5):1570-3. PubMed ID: 804519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cell-mediated cytotoxicity. II. Synergism of two types of thymus dependent cells in vivo.
    Sabbadini E
    Cell Immunol; 1975 Jul; 18(1):76-87. PubMed ID: 237633
    [No Abstract]   [Full Text] [Related]  

  • 16. Early steps in specific tumor cell lysis by sensitized mouse T lymphocytes. V. Evidence that manganese inhibits a calcium-dependent step in programming for lysis.
    Gately MK; Martz E
    Cell Immunol; 1981 Jun; 61(1):78-89. PubMed ID: 6167369
    [No Abstract]   [Full Text] [Related]  

  • 17. The genetic control of T cell-meditated immunity. I. Characterization of a mouse strain whose low responsiveness is inherited as a recessive trait.
    Vachek H; Kölsch E
    Immunology; 1974 Oct; 27(4):507-15. PubMed ID: 4215740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blocking activity of antisera raised to either tumor antigens or alloantigens in cytotoxicity assays using syngeneic or allogeneic killer cells on the P815 murine mastocytoma target.
    Al-Rammahy AK; Levy JG
    Cell Immunol; 1980 Dec; 56(2):338-46. PubMed ID: 6781763
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the mechanism of lymphocyte-mediated cytolysis. X. Enucleated cells as targets for cytotoxic attack.
    Siliciano RF; Henney CS
    J Immunol; 1978 Jul; 121(1):186-91. PubMed ID: 97346
    [No Abstract]   [Full Text] [Related]  

  • 20. Tumor cell destruction by cytotoxic T lymphocytes: the basis of reduced antitumor cell activity in syngeneic hosts.
    Fishelson Z; Berke G
    J Immunol; 1981 May; 126(5):2048-52. PubMed ID: 6783702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.